High-dose cyclophosphamide plus carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study Article

Toh, HC, McAfee, SL, Sackstein, R et al. (2000). High-dose cyclophosphamide plus carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study . 25(1), 19-24. 10.1038/sj.bmt.1702091

cited authors

  • Toh, HC; McAfee, SL; Sackstein, R; Multani, P; Cox, BF; Garcia-Carbonero, R; Colby, C; Spitzer, TR

sustainable development goals

publication date

  • January 1, 2000

keywords

  • BONE-MARROW
  • Biophysics
  • CANCER
  • GRAFT
  • Hematology
  • Immunology
  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology
  • Transplantation
  • adoptive immunotherapy
  • graft-versus-tumor effect
  • high dose chemotherapy and stem cell transplantation
  • interleukin-2
  • metastatic breast cancer

Digital Object Identifier (DOI)

publisher

  • STOCKTON PRESS

start page

  • 19

end page

  • 24

volume

  • 25

issue

  • 1